Colgate (CL) Director John T. Cahill Exercises Options, Sells 4,170 Shares

What Happened John T. Cahill, a director of Colgate-Palmolive Co. (CL), exercised stock options and immediately sold the resulting 4,170 shares on August 6, 2026. He exercised 4,170 option shares at $71.56 per share (total cost $298,405) and sold 4,170 common shares at a weighted-average price of $93.37 per share (total proceeds $389,358). The net difference between sale proceeds and exercise cost is about $90,953 (before taxes/fees). A derivative disposition at $0 reflects the options converted into shares on exercise.

Key Details

• Transaction date: 2026-08-06 (reported 2026-08-07)
• Exercise: 4,170 shares @ $71.56 = $298,405 (footnote F1: options awarded under the issuer’s incentive compensation plan)
• Sale: 4,170 shares @ weighted avg $93.37 = $389,358 (footnote F3: sale prices ranged $93.3712–$93.39)
• Derivative disposition: 4,170 shares @ $0.00 (reflects exercise/conversion of options)
• Footnote F2: a portion of the sale proceeds was delivered to the issuer to pay the exercise price (i.e., effectively a cashless exercise)
• Footnote F4: the options vested in equal annual installments over three years beginning May 13, 2019
• Shares owned after transaction: not disclosed in the provided excerpt
• Filing: Reported on 2026-08-07 for transactions on 2026-08-06 — appears timely (Form 4 is typically due within 2 business days)

Context This was an option exercise followed by an immediate sale (cashless exercise), a common way for insiders to monetize vested options. Such sell-upon-exercise transactions are routine and do not necessarily signal a change in the director’s view of the company. The filing notes the mechanics used to pay the exercise cost and provides a sale price range; additional per-price details can be obtained from the filer or SEC staff upon request.